Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  3. Endogenous Engineering Reprograms Extracellular Vesicles For Enhanced Therapeutic Function.
  1. Home
  3. Endogenous Engineering Reprograms Extracellular Vesicles For Enhanced Therapeutic Function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

China's carbon emissions trading system (ETS) helps the country slow down industrial solid waste accumulation.

Journal of the Air & Waste Management Association (1995)·2026
Same author

Inorganic nanomaterials empowering bacteria: a new paradigm for biomedical applications.

Journal of materials chemistry. B·2026
Same author

Nano-micro Combination: Overcoming Dual Intranasal Barriers to Elicit a Comprehensive Immune Response.

ACS applied materials & interfaces·2026
Same author

Development of 1 month core-shell microspheres combination formulation containing teriparatide for osteoporosis treatment.

Biomaterials·2026
Same author

Engineering lipid nanoparticle-stabilized emulsions for spatiotemporal mRNA delivery and enhanced T cell immunity.

Cell reports. Medicine·2026
Same author

Charge-reversal proteolysis polymers enable tissue-specific STING degradation in rheumatoid arthritis.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Current Collector Engineering for New Efficient Bioresorbable Sodium-Ion Batteries.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Thermally Driven Supramolecular Chirality Evolution in Low-Bandgap Fused-Ring Conjugated Molecules for High-Performance NIR Circularly Polarized Light Detection.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Oxygen Vacancy-Mediated Bi─O Unsaturation Coordination in BiOCl for Efficient Photocatalytic Water Purification.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Calcineurin-Dependent Stress Adaptation Enables Caspofungin Heteroresistance Leading to Stable Resistance in Candida Glabrata.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Recent Advances in Carbon Cathode Materials toward High-Performing Zinc-Ion Hybrid Supercapacitors.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Kinetic-Directed Thermodynamic Repair Enables the Synthesis of High-Strain 2D Sub-Stoichiometric COFs.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
See all related articles

Related Experiment Video

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

Endogenous Engineering Reprograms Extracellular Vesicles for Enhanced Therapeutic Function.

Jinghui Wang1,2, Wenxuan Zhao2, Xiaoming Hu2

  • 1Department of Gastroenterology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|May 25, 2026

View abstract on PubMed

Summary
This summary is machine-generated.

Researchers are reprogramming cells to engineer extracellular vesicles (EVs) for targeted drug delivery. This involves modifying cells genetically and environmentally to load proteins and nucleic acids for treating diseases like cancer and cardiovascular conditions.

Keywords:
endogenous engineeringextracellular vesiclesnucleic acidprotein cargotherapeutic applications

More Related Videos

Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy
09:34

Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy

Published on: May 18, 2017

Related Experiment Videos

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy
09:34

Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy

Published on: May 18, 2017

Area of Science:

  • Biotechnology
  • Cell Biology
  • Nanomedicine

Background:

  • Extracellular vesicles (EVs) are natural carriers of therapeutic molecules.
  • EV biogenesis pathways offer opportunities for cargo regulation.
  • Engineering EVs enhances their therapeutic potential.

Purpose of the Study:

  • To review strategies for reprogramming EV-producing cells to load functional proteins and nucleic acids.
  • To explore the combination of environmental cues and genetic programming for EV engineering.
  • To summarize therapeutic applications and future directions in EV-based therapeutics.

Main Methods:

  • Modulating cellular environments to influence EV cargo.
  • Genetic engineering of cells for protein and nucleic acid recruitment into EVs.
  • Utilizing intrinsic EV sorting machinery and engineered molecular interactions.
  • Leveraging RNA-binding proteins (RBPs) and sorting motifs for nucleic acid loading.

Main Results:

  • Demonstrated strategies for loading proteins via physiological stimuli and genetic systems (scaffold fusion, peptide tags).
  • Highlighted methods for enriching nucleic acids (miRNAs, mRNAs, RNP complexes) through environmental changes and targeted loading.
  • Summarized successful therapeutic applications in cardiovascular, hepatic, neurological diseases, and cancer.

Conclusions:

  • Cellular reprogramming offers a powerful approach for engineering EVs with specific therapeutic cargos.
  • Combined environmental and genetic strategies enhance the efficiency and specificity of EV loading.
  • Further advancements in discovery, biomanufacturing, and standardization are crucial for clinical translation of EV therapeutics.